The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon

Journal of the Neurological Sciences

Volumn 250, Issue 1-2, 2006, Pages 79-84

  Njamnshi, A K ^a,b   Mbong, E N ^a   Wonkam, A ^b   Ongolo Zogo, P ^a   Djientcheu, V de P ^a   Sunjoh, F L ^a   Wiysonge, C S ^c   Sztajzel, R ^b   Mbanya, D ^a   Blackett, K Ngu ^a   Dongmo, L ^a   Muna, W F T ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cameroon; Epidemiology; Sickle cell disease; Stroke; Sub Saharan Africa

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CAMEROON; CHILD; CONTROLLED STUDY; DISABILITY SEVERITY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEWBORN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RANKIN SCALE; RECURRENCE RISK; SICKLE CELL ANEMIA; STROKE;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CAMEROON; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSTIC ERRORS; DISABILITY EVALUATION; FEMALE; HUMANS; INFANT; MALE; PREVALENCE; QUALITY OF HEALTH CARE; RECURRENCE;

EID: 33750507214     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.07.003     Document Type: Article

References (26)

1. Platt O.S., Brambilla J.D., Rosse F.W., et al. Mortality in sickle cell disease: life expectancy and risk for early death. N Engl J Med 330 23 (1994) 1639-1644
2. Adams R.J., Ohene-Frempong K., and Wang W. Sickle cell and the brain. Am J Hematol 1 (2001) 31-46
3. Driscoll MC., Hurlet A., Styles L., Mckie V., Files B., Olivieri N., et al. Stroke risk in sibling with sickle cell anaemia. Blood 101 6 (2003) 2401-2404
4. Wethers DL. Sickle cell disease in childhood: part II. Diagnosis and treatment of major complications and recent advances in treatment. Am Fam J 62 6 (2000 (Sept 15)) 1309-1314
5. Pegelow C.H. Stroke in children with sickle cell anaemia: aetiology and treatment. Pediatria 3 6 (2001) 421-432
6. Adams R.J., Mckie V.C., Hsu L., Files B., Vichinsky E., Pegelow C., et al. Prevention of a first stroke by transfusions in children with sickle cell anaemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339 1 (1998) 5-11
7. Sumoza A., de Bisotti R., Sumoza D., and Fairbanks V. Hydroxyurea (HU) for the prevention of reccurent stroke in sickle cell anaemia (SCA). Am J Hematol 71 3 (2002) 161
8. Walters M.C., Storb R., Patience M., et al. Impact of bone marrow transplantation for symtomatic sickle cell disease: an interim report. Blood 95 (2000) 1918-1924
9. Ministry of Public Health, Department of Disease Control, Sub-Department of Non Endemic Diseases, Yaounde-Cameroon. Plan Stratégique National de Lutte contre la Drépanocytose au Cameroun; 2005.
10. Obama M.T., Dongmo L., Nkemayim C., Mbede J., and Hagbe P. Stroke in children in Yaounde, Cameroon. Indian Pediatr 31 7 (1994) 791-795
11. Mbonda E., Thuret I., and Pinsard N. Ischemic cerebrovascular accidents in homozygous sickle cell anemia: two case reports. Ann Pediatr 40 1 (1993) 23-27
12. Njamnshi A.K., Chetcha B., Ngang P., Djientcheu Vd.P., Ongolo-Zogo P., Dongmo L., et al. Stroke in sickle cell children: the need for more studies. Cameroon J Med 1 1 (2003) 32
13. WHO:http://www.who.int/ncd_surveillance/steps/stroke/en/steps_stroke_manual (v1.4).pdf p11.
14. Neonato M.G., Guilloud-Bataille M., Beauvais P., et al. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol 65 (2000) 155-164
15. Ohene-Frempong K., Weiner S.J., Sleeper L.A., Miller S.T., Moohr J., Wethers D., et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91 1 (1998) 288-294
16. Zamedjo E. Etude du polymorphisme des hémoglobines humaines à Yaoundé par la méthode d'isoélectrofocalisation. Thèse de Doctorat en Médecine. CUSS, Université de Yaoundé I; 1983.
17. Benz E.J. Hemoglobinopathies. In: Fauci K.H., et al. (Ed). Harrisson's Principle and Practice of Internal Medicine vol. 15 (2000), McGraw Hill Inc., USA 666-673
18. Lapoumeroulie C., Dunda O., Ducrocq R., Trabuchet G., Mony-Lobe M., Bodo J.M., et al. A novel sickle cell mutation of yet another origin in Africa: the Cameroon type. Hum Genet 89 3 (1992 (May)) 333-337
19. Sarnaik S.A., and Ballas S.K. Molecular characteristics of paediatric patients with sickle cell anaemia and stroke. Am J Hematol 67 3 (2001) 179-182
20. Lyra I.M., Goncalves M.S., Braga J.A., Gesteira Mde F., Carvalho M.H., Saad S.T., et al. Clinical, hematological, and molecular characterization of sickle cell anemia pediatric patients from two different cities in Brazil. Cad Saude Publica 21 4 (2005 (Jul-Aug)) 1287-1290
21. Njamnshi A.K., Wonkam A., Djientcheu V.de.P., Ongolo-Zogo P., Obama M.T., Muna W.F.T., et al. Stroke may appear to be rare in Saudi-Arabian and Nigerian children with sickle cell disease but not in Cameroonian sickle cell patients. Br J Haematol 133 2 (2006 (Apr)) 210
22. Balkaran B., Char G., Morrris J.S., et al. stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 120 (1992) 360-366
23. Schlegel D., Kolb S.J., Luciano J.M., Tovar J.M., et al. Utility of the NIH stroke scale as a predictor of hospital disposition. Stroke 34 (2003) 134-137
24. Dobson S.R., Holde K.R., Nietert P.J., Laver J.H., Disco D., and Abboud M.R. Moyamoya Syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 99 9 (2002) 3144-3150
25. Adams R., Mckie V., Nicholas F., et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 326 (1992) 605-610
26. Njamnshi A.K., Mbong E.N., Ongolo-Zogo P., Djientcheu V., Dongmo L., Mbanya D., et al. Stroke in sickle cell patients in Yaounde. J Neurol Sci 238 1 (2005) S424 Abstracts of the VIII World Congress of Neurology (Nov 5-11, 2005), Sydney-Australia.